About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » Erythropoietin (EPO) - Facts and Mode of Action

Erythropoietin (EPO) - Facts and Mode of Action News, Research and Latest Updates

Keep abreast with the latest news related to Erythropoietin (EPO) - Facts and Mode of Action there are 13 news items on Erythropoietin (EPO) - Facts and Mode of Action that covers updates, breakthroughs and in-depth reports.

We provide you with a free downloadable secure widget for your website to carry news related to Erythropoietin (EPO) - Facts and Mode of Action.

Erythropoietin (EPO) - Facts and Mode of Action

Erythropoietin is a hormone secreted by kidneys in response to low oxygen levels in tissues (hypoxia), and stimulates red cell formation in bone marrow.

SiRNA Drug can Boost EPO Production by Stimulating Liver in Anemia Patients

SiRNA Drug can Boost EPO Production by Stimulating Liver in Anemia Patients

Using a small interfering RNA (siRNA) drug to stimulate natural EPO production by the liver can help avoid the risks.

EPO Associated With Reduced Risk of Brain Abnormalities in Preterm Infants

EPO Associated With Reduced Risk of Brain Abnormalities in Preterm Infants

High-dose erythropoietin (EPO; a hormone) administered within 42 hours of birth to preterm infants was associated with a reduced risk of brain injury, as indicated by magnetic resonance imaging (MRI).

Effects of EPO and the Regulation of Cancer Stem Cell Growth and Survival

Effects of EPO and the Regulation of Cancer Stem Cell Growth and Survival

Non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide in recent years.

Advertisement

Study: Single, High-dose Erythropoietin Given 2 Days Pre-op Reduces Need for Transfused Blood

Study: Single, High-dose Erythropoietin Given 2 Days Pre-op Reduces Need for Transfused Blood

In non-cardiac and cardiac surgical procedures, anemia increases operative mortality and morbidity.

EPO may Not Gain Any Performance Advantage in Cyclists

EPO may Not Gain Any Performance Advantage in Cyclists

Scientists revealed that cyclists who dope themselves with EPO may not gain any performance advantage even though they are putting their health at risk.

Excessive Intake of EPO Could Lead to Serious Vascular Problems

Excessive Intake of EPO Could Lead to Serious Vascular Problems

Swiss researchers have warned that excessive usage of performance enhancing substance erythropoietin, popularly known as EPO, could lead to serious vascular problems

Advertisement

Outcomes of Erythropoietin Use for Heart Attack Patients Undergoing PCI Examined

Outcomes of Erythropoietin Use for Heart Attack Patients Undergoing PCI Examined

Epoetin alfa is a product that stimulates red blood cell production.

Increased Risk of Death Associated With High Erythropoietin Levels

Increased Risk of Death Associated With High Erythropoietin Levels

A study published in CMAJ (Canadian Medical Association Journal) says that high erythropoietin levels in people over age 85 indicate a higher risk of death.

Erythropoietin Boosts Brainpower: Study

Erythropoietin Boosts Brainpower: Study

Healthy young mice treated with erythropoietin show lasting improved performance in learning and other higher brain functions.

Advertisement

EPO Hormone After Myocardial Infarction Could Limit Heart Damage

EPO Hormone After Myocardial Infarction Could Limit Heart Damage

A single intravenous dose of hormone erythropoietin (EPO) immediately after myocardial infarction could limit heart damage.

Download Erythropoietin (EPO) - Facts and Mode of Action News Widget

Recommended Reading

Trade name - Erythropoietin

Trade name - Erythropoietin

Trade name - Erythropoietin

Erythropoietin

This medication is a haematopoietic agent, prescribed for anemia in people with chronic kidney ...

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional